Gabelli Funds »

Halozyme Therapeutics shares owned by Gabelli Funds

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Gabelli Funds from 13F filings

Historical chart of Gabelli Funds investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Gabelli Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Gabelli Funds

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.5M 125k 52.36
2024-03-31 $5.1M 125k 40.68
2023-12-31 $4.3M 115k 36.96
2023-09-30 $3.4M 90k 38.20
2023-06-30 $3.0M 84k 36.07
2023-03-31 $3.2M 84k 38.19
2022-12-31 $1.0M 18k 56.90
2022-09-30 $593k 15k 39.53
2022-06-30 $660k 15k 44.00
2021-12-31 $201k 5.0k 40.20